Bringing Engineering and Medicine Together
Dr. Steven J. Jonas, MD, PhD, is a physician-scientist at the University of California, Los Angeles (UCLA), whose work combines pediatric medicine, engineering, and nanotechnology. His research explores how extremely small technologies can help scientists understand disease and develop more precise ways to diagnose and treat cancer.
Dr. Jonas is an assistant professor in the Department of Pediatrics at the David Geffen School of Medicine at UCLA. He also serves as associate program director of UCLA’s Pediatric Hematology/Oncology Fellowship Program, helping train physicians who specialize in blood disorders and cancer in children.
His educational background reflects his interdisciplinary approach. He earned both his medical degree and a PhD in materials science and engineering from UCLA. This combination allows him to approach medical challenges not only from the perspective of patient care but also through the development of new scientific tools and technologies.
Exploring the Potential of Nanotechnology
Nanotechnology involves engineering and studying materials at an extremely small scale, where their properties can be useful for scientific and medical applications. In cancer research, these tools may help researchers investigate how tumors develop, how cancer cells respond to treatment, and how medicines might be delivered more effectively.
Dr. Jonas leads research exploring how nanoscale technologies can be used to investigate cancer and other diseases. His laboratory brings together engineering principles and biological research to develop tools that may help scientists study complex disease processes.
This work is important because cancer is not a single disease. Different tumors can behave differently, even when they affect the same organ. Better methods for studying these differences may help researchers identify biological characteristics that could eventually guide more individualized treatment approaches.
Although many nanotechnology applications remain experimental, the field offers opportunities to improve how scientists investigate diseases and evaluate potential therapies.
Supporting the Next Generation of Cancer Specialists
Alongside his research, Dr. Jonas contributes to medical education through his leadership in UCLA’s pediatric hematology and oncology fellowship program. Training specialists is an essential part of improving cancer care because advances in research must be matched by clinicians who understand how to evaluate and apply new evidence.
Pediatric oncology presents particular challenges. Children with cancer may require treatment strategies that consider not only the disease itself but also growth, development, and potential long-term effects. Research that improves the understanding of cancer biology may contribute to future approaches designed around these needs.
Dr. Jonas’s combination of laboratory investigation, clinical expertise, and educational leadership places him at the intersection of several important areas of medicine.
Recognition for Innovative Research
In June 2026, UCLA Health published a profile highlighting Dr. Jonas’s work with nanotechnology and its potential applications in cancer and disease research. The feature emphasized the innovative tools his laboratory is developing to explore medical problems from new perspectives.
The recognition reflects a growing interest in research that combines traditionally separate disciplines. Engineering, materials science, and medicine increasingly work together to address problems that cannot be solved through a single field alone.
Looking Toward the Future
Dr. Steven J. Jonas represents an emerging generation of physician-scientists who combine patient-focused medicine with advanced technology. His research does not promise an immediate cure for cancer, but it contributes to the scientific tools and knowledge that may support future breakthroughs.
By investigating nanotechnology, mentoring future specialists, and working within UCLA’s pediatric research community, he is helping advance the scientific foundations of tomorrow’s treatments.
His career illustrates how combining different areas of expertise can open new avenues for medical discovery and help researchers ask questions that might otherwise remain unanswered.
